Skip to main content
Premium Trial:

Request an Annual Quote

David Rimoin Dies

David Rimoin, geneticist and founding president of the American College of Medical Genetics and Genomics, has died, ACMG reports. He was 75. The Los Angeles Times adds that Rimoin "pioneered studies of dwarfism and other skeletal abnormalities." Additionally, the LA Times notes he was "among the first to recognize that diabetes is caused by a variety of genetic abnormalities and he played an influential role in establishing screening programs for Tay-Sachs disease." In a statement, current ACMG President Wayne Grody says that "for most of the formative years of our specialty, David was the face of medical genetics to the rest of organized medicine and to the public."

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.